Contract 75A50325F80025
Heyltex Corporation · Department Of Health And Human Services · September 27, 2025
Heyltex Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2025 for $8.10 million of work in pharmaceutical preparation manufacturing. Performance is in Katy, TX. This is a task or delivery order issued under parent IDIQ V797D70258. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $16.20 million.
Contract details
- PIID
- 75A50325F80025
- Parent IDIQ
- V797D70258
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Katy, TX
- First action
- September 27, 2025
Description
PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG
Modification timeline
-
September 27, 2025Base award$8.10M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325F80025?
Contract 75A50325F80025 is a federal contract awarded to Heyltex Corporation by Department Of Health And Human Services on September 27, 2025 for $8.10 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50325F80025?
Heyltex Corporation won contract 75A50325F80025 from Department Of Health And Human Services.
How much is contract 75A50325F80025 worth?
Contract 75A50325F80025 has obligated $8.10 million to date, with a total potential value of $16.20 million if all options are exercised.